Together we will beat cancer

Donate

Targeted treatment for leukaemia approved on NHS in England 

The targeted drug gilteritinib is now recommended for some adults with acute myeloid leukaemia (AML) on the NHS in England.  

Read More

Three new treatment options approved for NHS use in Scotland

The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland

Read More

Leukaemia and head and neck cancer drugs not approved for NHS use in England

Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England.

Read More

New treatment option for certain leukaemia patients in Scotland

A targeted combination treatment for patients with a specific type of blood cancer will soon be available on the NHS in Scotland.

Read More

Three new cancer treatments available for NHS patients in Scotland

A breast cancer drug and two blood cancer treatments have been recommended for use on the NHS in Scotland.

Read More

NICE U-turn opens up new treatment option for some adults with leukaemia

Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England.

Read More

Three cancer drugs cleared for NHS funding in Scotland

Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer.

Read More

Leukaemia drug gets initial ‘no’ for NHS in England

Patients with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for NHS use in England.

Read More

Double NHS decision for CAR T cell immunotherapy in Scotland

Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer.

Read More

First patient receives CAR T cell therapy on NHS

An 11-year-old boy became the first NHS patient to receive a personalised blood cancer immunotherapy on the NHS.

Read More